336 related articles for article (PubMed ID: 31683891)
1. Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.
Lokau J; Schoeder V; Haybaeck J; Garbers C
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683891
[TBL] [Abstract][Full Text] [Related]
2. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
3. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
4. JAK/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B.
Dong Y; Li X; Yu Y; Lv F; Chen Y
Life Sci; 2020 Jul; 252():117663. PubMed ID: 32302624
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
7. Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer.
Zundler S; Neurath MF
Vaccines (Basel); 2016 Feb; 4(1):. PubMed ID: 26938566
[TBL] [Abstract][Full Text] [Related]
8. Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes.
Singh A; Jayaraman A; Hahn J
Biotechnol Bioeng; 2006 Dec; 95(5):850-62. PubMed ID: 16752369
[TBL] [Abstract][Full Text] [Related]
9. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling.
Kurdi M; Booz GW
J Cardiovasc Pharmacol; 2007 Aug; 50(2):126-41. PubMed ID: 17703129
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
11. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
Lokau J; Garbers C
Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways.
Ahmed ST; Ivashkiv LB
J Immunol; 2000 Nov; 165(9):5227-37. PubMed ID: 11046056
[TBL] [Abstract][Full Text] [Related]
14. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction.
Schieffer B; Luchtefeld M; Braun S; Hilfiker A; Hilfiker-Kleiner D; Drexler H
Circ Res; 2000 Dec; 87(12):1195-201. PubMed ID: 11110778
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic study of interaction between IL-22 and HCV core protein in the development of hepatocellular carcinoma among liver transplant recipients.
Resham S; Saalim M; Manzoor S; Ahmad H; Bangash TA; Latif A; Jaleel S
Microb Pathog; 2020 Feb; 142():104071. PubMed ID: 32074496
[TBL] [Abstract][Full Text] [Related]
16. The JAK/STAT Pathway in Skeletal Muscle Pathophysiology.
Moresi V; Adamo S; Berghella L
Front Physiol; 2019; 10():500. PubMed ID: 31114509
[TBL] [Abstract][Full Text] [Related]
17. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
[TBL] [Abstract][Full Text] [Related]
18. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and Interferon-α Signaling
Danziger O; Pupko T; Bacharach E; Ehrlich M
Front Immunol; 2018; 9():94. PubMed ID: 29441069
[TBL] [Abstract][Full Text] [Related]
20. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH
J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
